Diagnostic Specialty Antibodies Market (Antibody - Polyclonal Antibodies, Monoclonal Antibodies, and Recombinant Polyclonal Antibodies; Application - Tuberculosis Diagnostics, Hepatitis Diagnosis, Dengue Diagnostics, HIV Diagnostics, Infectious Disease Diagnostics, Oncology Diagnostics, and Other Application; End user - Hospitals, Diagnostic Laboratories, and Other End Users): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : October, 2019

  • Rep Id : HC0698

  • Category : Healthcare & Medical Devices

  • Status : Published

A recent report published by Infinium Global Research on diagnostic specialty antibodies market provides an in-depth analysis of segments and sub-segments in the global as well as regional diagnostic specialty antibodies market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional diagnostic specialty antibodies market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global diagnostic specialty antibodies market. According to the report, the global diagnostic specialty antibodies market is projected to grow at a CAGR of 5.2% over the forecast period of 2019-2025.


Market Insight

The growing patient pool of HIV diagnosis is one of the major factors for the growth of the diagnostic specialty antibodies market across the globe. According to the World Health Organization, an estimated 1.1 million people aged 13 and older had HIV infection in the United States in 2016, including an expected 162,500 (14%) people whose infections had not been diagnosed. In 2017, the sum of new HIV diagnoses in the United States and 6 dependent areas were 38,739. Furthermore, high unmet needs in the market, advanced research and developments are the other key factors that boost the growth of the diagnostic specialty antibodies market. However, the failure of antibodies in a rapid diagnostic test for routine diagnosis and high cost of monoclonal antibodies are some of the major factors that may restrain the market growth over the forecast period. Moreover, the launch of novel products and technological advancements creates beneficial opportunities for diagnostic specialty antibodies market in the upcoming years.


In terms of region, North America is leading the diagnostic specialty antibodies market during the forecast period. This is primarily due to the growing demand for specialty antibody diagnostics for human immunodeficiency virus (HIV), hepatitis delta virus (HDV), and another infectious disease diagnosis. Furthermore, the increase in the adoption of various antibody kits in hospitals and private clinics also helps in the growth of diagnostic specialty antibodies market in the North American region. On the other hand, Europe is expected to be the second-largest region in the diagnostic specialty antibodies market over the forecast period. The surge in the frequency of infectious diseases, a large patient pool for HIV diagnosis are some key factors for the growth of the market in the region. In addition, the availability of technologically advanced research and development platforms for the diagnosis of disorders and the launch of innovative and advanced kits by major manufacturers also boosts the market growth in the European region.


Segment Covered

The report on global diagnostic specialty antibodies market covers segments such as an antibody, application, and end user. On the basis of antibody, the sub-markets include polyclonal antibodies, monoclonal antibodies, and recombinant polyclonal antibodies. On the basis of application, the sub-markets include tuberculosis diagnostics, hepatitis diagnosis, dengue diagnostics, HIV diagnostics, infectious disease diagnostics, oncology diagnostics, and other application. On the basis of end user, the sub-markets include hospitals, diagnostic laboratories, and other end users.


Companies Profiled:

The report provides profiles of the companies in the market such as F. Hoffmann-La Roche AG, Sanofi S.A., Abbott Laboratories, Abcam plc. Bio-Rad Laboratories, Inc., Enzo Life Sciences, Inc., Boehringer Ingelheim International GmbH, Agilent Technologies, Inc., Aytu BioScience, Inc., and Polymun Scientific Immunbiologische Forschung GmbH.


Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of diagnostic specialty antibodies market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount